Yellow fever, historically limited to Africa and South America, now presents a growing threat in the Asia-Pacific region due to factors like international travel, climate change, and urbanization.
The virus, primarily transmitted by Aedes mosquitoes, may lead to severe disease with mortality rates between 20-50% in severe cases in humans.
Early and accurate identification of yellow fever cases in Asia-Pacific is hampered by inadequate surveillance infrastructure, hindering prompt response.
Vaccination remains crucial for prevention, but vaccination coverage in the Asia-Pacific region is currently minimal, necessitating proactive immunization strategies.
Integrated vector management, including targeted insecticide use and community engagement, is vital to curb potential yellow fever spread alongside dengue and chikungunya viruses.
The convergence of factors such as urbanization, inadequate infrastructure, and international travel intensifies the yellow fever threat in the Asia-Pacific region.
Genetic diversity of the yellow fever virus poses challenges, necessitating monitoring for mutations that could impact transmission and virulence.
Enhancing clinical awareness and training healthcare providers is crucial to ensure timely recognition and management of yellow fever cases, given diagnostic challenges.
Lessons from recent flavivirus emergences in Asia-Pacific offer valuable frameworks for strategic and efficient response efforts against yellow fever.
International cooperation, information sharing, harmonized vaccination policies, and joint vector control initiatives are essential for yellow fever preparedness in the Asia-Pacific region.